HGH Fragment 176-191
HGH Fragment 176-191 is a stabilized piece of human growth hormone (amino acids 176-191) and the parent compound of AOD-9604. Research focuses on fat breakdown without the growth-promoting or blood sugar effects of full growth hormone.
Verified sources for HGH Fragment 176-191
These vendors are vetted by PeptideWiki for purity testing and COA transparency.
Overview of HGH Fragment 176-191
Stimulates lipolysis and fat oxidation through a GH-receptor-independent mechanism, targeting adipose tissue without affecting IGF-1, glucose metabolism, or growth.
Mimics the lipolytic region of human growth hormone, stimulating hormone-sensitive lipase activity in adipose tissue.
Promotes fat oxidation and release of free fatty acids from adipocytes (proposed), particularly from stubborn visceral and abdominal fat stores.
Works independently of the GH receptor, meaning it does not elevate IGF-1 or promote tissue growth.
Does not affect blood glucose levels or insulin sensitivity (proposed), lacking the diabetogenic properties of full GH.
Does not promote longitudinal bone growth or organ hypertrophy, isolating the fat-metabolizing portion of GH.
Precursor to AOD-9604, which adds a tyrosine residue for improved stability but shares the same core mechanism
Read Full HGH Fragment 176-191 Dosage Guide
Research-backed dosing protocols, timing, and administration details
Browse more in this category
Metabolic & Weight Loss